1. Leukemia. 2017 Jan;31(1):234-237. doi: 10.1038/leu.2016.249. Epub 2016 Aug 30.

Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective 
immunotherapeutic target.

Alatrash G(1), Garber HR(#)(1), Zhang M(#)(1), Sukhumalchandra P(1), Qiu Y(2), 
Jakher H(1), Perakis AA(1), Becker L(1), Yoo SY(3), Dwyer KC(1), Coombes K(4), 
Talukder AH(5), John LSS(1), Senyukov V(6), Lee DA(6), Sergeeva A(1), He H(1), 
Ma Q(1), Armistead PM(7), Roszik J(5)(8), Mittendorf EA(9), Molldrem JJ(1), 
Hawke D(10), Lizee G(5), Kornblau SM(2).

Author information:
(1)Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, 
Houston, TX.
(2)Leukemia, MD Anderson Cancer Center, Houston, TX.
(3)Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, 
TX.
(4)Biomedical Informatics, Ohio State University, Columbus, OH.
(5)Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX.
(6)Pediatrics, MD Anderson Cancer Center, Houston, TX.
(7)Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel 
Hill, NC.
(8)Genomic Medicine, MD Anderson Cancer Center, Houston, TX.
(9)Surgical Oncology, MD Anderson Cancer Center, Houston, TX.
(10)Systems Biology, MD Anderson Cancer Center, Houston, TX.
(#)Contributed equally

DOI: 10.1038/leu.2016.249
PMCID: PMC5215491
PMID: 27573556 [Indexed for MEDLINE]